← SynDRA
TARIQUIDAR
SynDRA canonical compound SYN0005172 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ABCB1 |
|---|
| Mechanism of action | P-glycoprotein inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- P-glycoprotein inhibitor
- ABCB1 INHIBITOR
- P-glycoprotein 1 inhibitor
- P glycoprotein inhibitor
- ABCB1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCG2
- CYP2C9
- ABCC1
- ABCC2
- CYP1A2
- CYP2A6
- CYP2B6
- CYP2C19
- CYP2C8
- CYP2D6
- CYP2E1
- CYP3A4
- HDAC6
Cross-references
Synonyms
- XR-9576
- XR9576
- Tariquidarth
- XR 9576
- Tariquidar (USAN/INN)
- N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide
- N-(2-((4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)carbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide
- J58862DTVD
- tariquidarth
- tariquidarum
- RefChem:891172
- DTXCID6097237
- C38H38N4O6
- MFCD09837824
- Tariquidar [USAN]
- UNII-J58862DTVD
- Tariquidar [USAN:INN:BAN]
- R1H
- TARIQUIDAR [MI]
- TARIQUIDAR [INN]
- Tariquidar (XR9576)?
- TARIQUIDAR [WHO-DD]
- MLS006011218
- SCHEMBL104163
- orb1300901
- SCHEMBL21545178
- SCHEMBL29387021
- SCHEMBL29558585
- Tariquidar, >=98% (HPLC)
- GTPL11787
- EX-A231
- CHEBI:177609
- GLXC-90256
- HMS3653L21
- BDBM50075373
- s8028
- AKOS016008964
- CCG-270326
Look up TARIQUIDAR in the interactive SynDRA portal →